In Vitro in Vivo Evaluation of Niosomal Formulation of Famotidine

International Journal of Pharmacy and Pharmaceutical Sciences - India
doi 10.22159/ijpps.2020v12i3.36210
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Innovare Academic Sciences Pvt Ltd

Related search

Formulation and Evaluation of Famotidine Sublingual Tablets

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2005English

Formulation and in Vitro, in Vivo Evaluation of Proniosomal Gel of Neomycin Sulphate

International Journal of Applied Pharmaceutics
Pharmaceutical Science
2019English

Formulation of Meloxicam Gel for Topical Application: In Vitro and in Vivo Evaluation

Acta Pharmaceutica
MedicinePharmacologyPharmaceutical Science
2010English

Formulation and Development of Fluoxetine Transdermal Patches: In Vitro and in Vivo Evaluation

International Journal of Pharmaceutical Research and Innovation
2016English

Evaluation of Gastric and Duodenal Antiulcer Activity of Famotidine Formulation in Experimental Animals

Journal of Pharmacology and Toxicology
ToxicologyPharmaceuticsPharmacology
2011English

Formulation and Evaluation of Niosomal in Situ Gel of Prednisolone Sodium Phosphate for Ocular Drug Delivery

International Journal of Applied Pharmaceutics
Pharmaceutical Science
2019English

Proniosomal Telmisartan Tablets: Formulation, in Vitro Evaluation and in Vivo Comparative Pharmacokinetic Study in Rabbits

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2020English

Formulation and in Vitro Evaluation of Antioxidant Activity of Herbal Sunscreen Formulation

International Research Journal of Pharmacy
2020English

Furosemide Loaded Silica-Lipid Hybrid Microparticles: Formulation Development, in Vitro and Ex Vivo Evaluation

Advanced Pharmaceutical Bulletin
ToxicologyPharmaceuticsPharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy